1. Bakhti, Mostafa, Bastidas-Ponce, Aimée, Tritschler, Sophie, Coskun, Ünal, Lickert, Heiko. 2022. Synaptotagmin-13 orchestrates pancreatic endocrine cell egression and islet morphogenesis. In Nature communications, 13, 4540. doi:10.1038/s41467-022-31862-8. https://pubmed.ncbi.nlm.nih.gov/35927244/
2. Nizzardo, M, Taiana, M, Rizzo, F, Hedlund, E, Corti, S. 2020. Synaptotagmin 13 is neuroprotective across motor neuron diseases. In Acta neuropathologica, 139, 837-853. doi:10.1007/s00401-020-02133-x. https://pubmed.ncbi.nlm.nih.gov/32065260/
3. Zhang, Liyan, Fan, Bijun, Zheng, Yu, Zhang, Tiancheng, Tan, Xiaoming. 2019. Identification SYT13 as a novel biomarker in lung adenocarcinoma. In Journal of cellular biochemistry, 121, 963-973. doi:10.1002/jcb.29224. https://pubmed.ncbi.nlm.nih.gov/31625195/
4. Tarquis-Medina, Marta, Scheibner, Katharina, González-García, Ismael, Lickert, Heiko, Bakhti, Mostafa. 2021. Synaptotagmin-13 Is a Neuroendocrine Marker in Brain, Intestine and Pancreas. In International journal of molecular sciences, 22, . doi:10.3390/ijms222212526. https://pubmed.ncbi.nlm.nih.gov/34830411/
5. Ichikawa, Takahiro, Shibata, Masahiro, Inaishi, Takahiro, Kodera, Yasuhiro, Kikumori, Toyone. 2021. Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer. In Current oncology (Toronto, Ont.), 28, 4080-4092. doi:10.3390/curroncol28050346. https://pubmed.ncbi.nlm.nih.gov/34677264/
6. Ofori, Jones K, Karagiannopoulos, Alexandros, Barghouth, Mohammad, Wendt, Anna, Eliasson, Lena. 2022. The highly expressed calcium-insensitive synaptotagmin-11 and synaptotagmin-13 modulate insulin secretion. In Acta physiologica (Oxford, England), 236, e13857. doi:10.1111/apha.13857. https://pubmed.ncbi.nlm.nih.gov/35753051/
智鼠故事 
